Obesity and polycystic ovary syndrome

Clinical Endocrinology - Tập 65 Số 2 - Trang 137-145 - 2006
TM Barber1,2, Mark I. McCarthy2, John Wass1, Stephen Franks3
1Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University, Oxford, UK,
2Diabetes Research Laboratories, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University, Oxford, UK and
3Institute of Reproductive and Developmental Biology, Imperial College London, UK

Tóm tắt

Summary

The aetiology of Polycystic Ovary Syndrome (PCOS) is complex and multifactorial. There is much evidence, however, to suggest that adipose tissue plays an important role in the development and maintenance of PCOS pathology. There is a close correlation between adiposity and symptom severity in women with PCOS, and even modest reductions in weight generally translate into significant improvements in menstrual regularity, fertility and hyperandrogenic features. This review article considers the various mechanisms that might underlie this link between excess adiposity and PCOS – including the effects of differential insulin sensitivity, abnormal steroid hormone metabolism and adipocytokine secretion. Greater attention to the therapeutic options available to reduce the impact of excess adiposity on ovarian and metabolic function is essential to the management of PCOS.

Từ khóa


Tài liệu tham khảo

10.1210/jc.85.7.2434

10.1046/j.1365-2265.2000.01000.x

10.1677/joe.0.1290317

10.1210/jc.79.5.1328

10.1111/j.1365-2265.1992.tb02909.x

10.1210/jc.80.9.2586

10.1111/j.1749-6632.2000.tb06230.x

10.1093/oxfordjournals.humrep.a136243

10.1210/jc.2002-020982

10.1210/jcem-50-1-113

10.2337/diab.38.9.1165

10.1210/er.18.6.774

10.1210/rp.56.1.295

10.1210/jcem-68-1-173

10.1210/jc.86.4.1626

10.1016/S0889-8529(18)30245-7

Franks S., 1996, The Ovary: Regulation, Dysfunction and Treatment, 183

10.1111/j.1365-2265.1995.tb02665.x

10.1111/j.1365-2265.1993.tb02376.x

10.1210/jc.83.11.3984

10.1210/endo-108-4-1441

10.1210/jcem-72-1-83

10.1210/jc.80.11.3227

10.1093/humrep/15.6.1266

10.1172/JCI7535

10.1152/ajpendo.1993.264.2.E197

10.1093/humrep/deh609

10.1210/jc.85.11.4182

10.1210/jc.82.5.1421

10.1159/000049972

10.1210/jc.78.5.1052

10.1093/humrep/deh137

10.1046/j.1365-2265.2002.01603.x

10.1210/jc.2004-1006

10.1093/humrep/16.6.1255

10.1002/ajpa.10364

10.1677/joe.0.1740001

10.1210/jc.82.7.2044

10.1210/jc.81.6.2198

10.1007/BF03347939

10.2337/diabetes.51.2.484

10.1210/endo-126-2-1229

Rebuffe‐Scrive M., 1991, Effect of testosterone on abdominal adipose tissue in men, International Journal of Obesity, 15, 791

10.1016/S0140-6736(63)91500-9

10.2337/diabetes.54.6.1706

10.2337/diabetes.52.4.910

10.1093/humrep/deg128

10.1111/j.1365-2265.2005.02261.x

10.1210/jc.87.2.772

10.1093/humrep/deh010

10.1111/j.1365-2265.1994.tb02578.x

10.1016/S0960-0760(03)00360-1

10.1677/joe.1.05762

10.1016/0140-6736(90)90664-Q

10.1210/jc.2002-021875

10.1159/000058374

10.1210/jc.2003-030433

10.1093/humrep/deh900

10.1093/hmg/6.3.397

Andrew R., 1998, Obesity and gender influence cortisol secretion and metabolism in man, Journal of Clinical Endocrinology and Metabolism, 83, 1806, 10.1210/jcem.83.5.4951

10.1210/jc.84.3.1022

10.1210/jc.2003-032240

10.1056/NEJM199402173300703

10.1210/jc.2003-030240

10.1515/JPEM.2000.13.3.253

10.1073/pnas.95.5.2541

10.1210/jc.81.11.4166

10.1210/jc.84.3.1072

10.1210/en.138.2.847

10.1038/nm1195-1155

10.1530/eje.0.1450289

10.1016/S0026-0495(98)90356-0

10.1016/S0015-0282(02)03303-4

10.1210/jcem.86.12.8111

10.1210/jc.2002-020776

10.1210/jc.2002-020505

10.1055/s-2004-814341

10.1007/BF03347020

10.1210/jc.2003-031583